Mehdi Valipour

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 16

Top Topics

Tyrosine Kinase

Gas Chromatography Mass Spectrometry

Respiratory Syndrome Coronavirus

Top Venues

ACS pharmacology & translational science

Phytotherapy research : PTR

Archiv der Pharmazie

This page only lists publications with an associated author ORCID identifier.

Publications

Zahra Zakeri Khatir, Antonella Di Sotto, Ester Percaccio, Tuba Tüylü Küçükkılınç, Ayse Ercan, Ann M Chippindale, Mehdi Valipour, Konstanze Miehle
4-{3-[(Pyridin-4-ylmethyl)amino]-[1,2,4]triazolo[4,3-b][1,2,4]triazin-6-yl}phenol: An improved anticancer agent in hepatocellular carcinoma and a selective MDR1/MRP modulator. Archiv der Pharmazie (2024)
Zahra Zakeri Khatir, Antonella Di Sotto, Ester Percaccio, Tuba Tüylü Küçükkılınç, Ayse Ercan, Ann M Chippindale, Mehdi Valipour, Konstanze Miehle
4-{3-[(Pyridin-4-ylmethyl)amino]-[1,2,4]triazolo[4,3-b][1,2,4]triazin-6-yl}phenol: An improved anticancer agent in hepatocellular carcinoma and a selective MDR1/MRP modulator. Archiv der Pharmazie 357 (6) (2024)
Zahra Zakeri Khatir, Antonella Di Sotto, Ester Percaccio, Tuba Tüylü Küçükkılınç, Ayse Ercan, Ann M Chippindale, Mehdi Valipour, Konstanze Miehle
4-{3-[(Pyridin-4-ylmethyl)amino]-[1,2,4]triazolo[4,3-b][1,2,4]triazin-6-yl}phenol: An improved anticancer agent in hepatocellular carcinoma and a selective MDR1/MRP modulator. Archiv der Pharmazie 357 (6) (2024)
Asieh Hosseini, Mohammad Sheibani, Mehdi Valipour
Exploring the Therapeutic Potential of BBB-Penetrating Phytochemicals With p38 MAPK Modulatory Activity in Addressing Oxidative Stress-Induced Neurodegenerative Disorders, With a Focus on Alzheimer's Disease. Phytotherapy research : PTR (2024)
Mehdi Valipour, Maryam Mohammadi, Habib Valipour
CNS-Active p38α MAPK Inhibitors for the Management of Neuroinflammatory Diseases: Medicinal Chemical Properties and Therapeutic Capabilities. Molecular neurobiology (2023)
Mehdi Valipour, Zahra Zakeri Khatir, Elaheh Abdollahi, Adileh Ayati
Recent Applications of Protoberberines as Privileged Starting Materials for the Development of Novel Broad-Spectrum Antiviral Agents: A Concise Review (2017-2023). ACS pharmacology & translational science 7 (1) (2023)
Antonella Di Sotto, Mehdi Valipour, Aala Azari, Silvia Di Giacomo, Konstanze Miehle
Benzoindolizidine Alkaloids Tylophorine and Lycorine and Their Analogues with Antiviral, Anti-Inflammatory, and Anticancer Properties: Promises and Challenges. Biomedicines 11 (10) (2023)
Mehdi Valipour, Zahra Zakeri Khatir, Elaheh Abdollahi, Adileh Ayati
Recent Applications of Protoberberines as Privileged Starting Materials for the Development of Novel Broad-Spectrum Antiviral Agents: A Concise Review (2017-2023). ACS pharmacology & translational science 7 (1) (2023)
Mehdi Valipour, Konstanze Miehle, Hossein Keyvani
An Overview on Anti-COVID-19 Drug Achievements and Challenges Ahead. ACS pharmacology & translational science 6 (9) (2023)
Mehdi Valipour, Silvia Di Giacomo, Antonella Di Sotto, Konstanze Miehle
Discovery of Chalcone-Based Hybrid Structures as High Affinity and Site-Specific Inhibitors against SARS-CoV-2: A Comprehensive Structural Analysis Based on Various Host-Based and Viral Targets. International journal of molecular sciences 24 (10) (2023)
Mehdi Valipour
Therapeutic prospects of naturally occurring p38 MAPK inhibitors tanshinone IIA and pinocembrin for the treatment of SARS-CoV-2-induced CNS complications. Phytotherapy research : PTR (2023)
Mehdi Valipour, Asieh Hosseini, Antonella Di Sotto, Konstanze Miehle
Dual action anti-inflammatory/antiviral isoquinoline alkaloids as potent naturally occurring anti-SARS-CoV-2 agents: A combined pharmacological and medicinal chemistry perspective. Phytotherapy research : PTR (2023)
Mehdi Valipour
Different Aspects of Emetine's Capabilities as a Highly Potent SARS-CoV-2 Inhibitor against COVID-19. ACS pharmacology & translational science 5 (6) (2022)
Mehdi Valipour
Recruitment of chalcone's potential in drug discovery of anti-SARS-CoV-2 agents. Phytotherapy research : PTR (2022)
Mehdi Valipour, Konstanze Miehle, Saeed Emami
Papaverine, a promising therapeutic agent for the treatment of COVID-19 patients with underlying cardiovascular diseases (CVDs). Drug development research 83 (6) (2022)
Mehdi Valipour, Afshin Zarghi, Mohammad Ali Ebrahimzadeh, Konstanze Miehle
Therapeutic potential of chelerythrine as a multi-purpose adjuvant for the treatment of COVID-19. Cell cycle (Georgetown, Tex.) 20 (22) (2021)